Under construction – not a live service
Sign in
SuspendedNo phase

Feasibility Study of the AffloVest in Bronchiectasis

Reason given: Data analysis review of current data

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Trial details

Who runs it
Papworth Hospital NHS Foundation Trust
Trial code
NCT04266873
Record updated
31 May 2025
Original description
Feasibility study of High Frequency Chest Wall Oscillation (HFCWO) using the AffloVest in 30 patients with Bronchiectasis over a 6 week period. Outcome measures include lung function, quality of life questionnaire, High resolution computed Tomography and visual analogue scale for ease of clearance.Read full original descriptionShow less

Measurement of Mucus Plugging With Computer Tomography Before and Following Implementation of the AffloVest in Adults With Bronchiectasis - a Feasibility Study'

Feasibility study of High Frequency Chest Wall Oscillation (HFCWO) using the AffloVest in 30 patients with Bronchiectasis over a 6 week period. Outcome measures include lung function, quality of life questionnaire, High resolution computed Tomography and visual analogue scale for ease of clearance.

Inclusion: Adult male and females 18 years or over; Current diagnosis of bronchiectasis; Productive of sputum on a daily basis; Clinical stability over a 2 week period prior to enrolment.

Exclusion: Severe obstructive airways disease (defined as FEV1 less than 25 percent); Predominant lung disease is not bronchiectasis in the opinion of the investigator (e.g. asthma, Chronic Obstructive Pulmonary Disease (COPD), pulmonary fibrosis); Currently treated non-tuberculous mycobacterial lung disease; Acute congestive cardiac failure; Contra-indication to using AffloVest including lung malignancy, recent rib fractures, radiological evidence of lung cavitation, and recent significant haemoptysis (in the opinion of the investigator); History of poor adherence to physiotherapy treatment; Cystic fibrosis; Bronchiectasis in only 1 lobe; Contra-indication or unable to perform HRCT imaging, including pregnancy; Cognitive or memory problems affecting ability to follow instructions or give informed consent.

ClinicalTrials.gov NCT04266873

Under construction, not live – Feasibility Study of the AffloVest in Bronchiectasis (NCT04266873) – Frontlight Research